Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Inventory (2018 - 2025)

Historic Change in Inventory for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $968000.0.

  • Dna X's Change in Inventory fell 8869.82% to $968000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 12069.15%. This contributed to the annual value of $5.0 million for FY2024, which is 9144.61% up from last year.
  • Latest data reveals that Dna X reported Change in Inventory of $968000.0 as of Q3 2025, which was down 8869.82% from $1.3 million recorded in Q2 2025.
  • Dna X's Change in Inventory's 5-year high stood at $8.6 million during Q3 2024, with a 5-year trough of -$2.7 million in Q4 2021.
  • In the last 5 years, Dna X's Change in Inventory had a median value of -$180000.0 in 2022 and averaged $92894.7.
  • As far as peak fluctuations go, Dna X's Change in Inventory plummeted by 38327.76% in 2024, and later skyrocketed by 12700000.0% in 2025.
  • Dna X's Change in Inventory (Quarter) stood at -$2.7 million in 2021, then surged by 93.44% to -$180000.0 in 2022, then surged by 1376.67% to $2.3 million in 2023, then crashed by 181.77% to -$1.9 million in 2024, then surged by 151.52% to $968000.0 in 2025.
  • Its Change in Inventory was $968000.0 in Q3 2025, compared to $1.3 million in Q2 2025 and -$2.3 million in Q1 2025.